This application relates to a surgical instrument for controlling bleeding at a surgical site, and more particularly, to a vessel harvesting device that includes a bleeding control feature.
In endoscopic vessel harvesting (EVH) surgical procedures, a long slender surgical instrument may be advanced into a tunnel next to the saphenous vein in a patient's leg, and along the saphenous vein to dissect the vessel away from adjacent tissue, and to sever side-branch vessels along the course of the vessel to be harvested. Similar technique may also be used to harvest a radial artery.
During the EVH procedure, vasculature in tunnel will occasionally bleed. This is a challenge for the individual performing the EVH procedure as well as for the patient. This is because blood may impair visualization of the target site during the procedure, and may cause wound complications for the patient. Existing instruments that perform EVH procedure do not provide bleeding control function to control bleeding at the tunnel. This is because the vessel harvesting instrument needs to have a low profile. Thus, providing an additional energy delivery feature in such instrument for controlling bleeding in the tunnel, which will increase the size of the instrument, is generally not desirable. Also, delivery of monopolar RF energy is not desirable for protecting a vessel. Thus, use of monopolar RF energy for bleeding control in a vessel harvesting procedure has been avoided.
In accordance with some embodiments, a surgical instrument includes an elongated body having a distal end, a proximal end, and a bore extending between the distal and proximal ends, a surgical device including electrically conductive material mounted on the distal end of the body, a handle coupled to the proximal end of the elongated body, the handle including a manual control moveably mounted thereon, linkage disposed within the bore, wherein the linkage couples the manual control to the surgical device, and is configured for actuating movement of the surgical device in response to manipulation of the manual control, and a contact region of electrically conductive material disposed at the handle, wherein the contact region is electrically connected to the surgical device; wherein in a first mode of operation, the electrically conductive material of the surgical device is configured to provide heat, and in a second mode of operation, the electrically conductive material of the surgical device is configured to provide radiofrequency (RF) energy. The two modes of operation may be performed at different times, or simultaneously.
In accordance with other embodiments, a surgical instrument includes an elongated body having a distal end, a proximal end, and a bore extending between the distal and proximal ends, a pair of jaws for severing vessel mounted on the distal end of the body, wherein at least one of the jaws has an electrically conductive material, and a handle coupled to the proximal end of the elongated body, wherein in a first mode of operation, the electrically conductive material is for receiving energy from a direct current (DC) source, and in a second mode of operation, the electrically conductive material is for receiving energy from a RF source.
In accordance with other embodiments, a method for controlling bleeding at a surgical site in a patient includes inserting a surgical device into the patient, the surgical device having an electrically conductive material, supplying energy from a DC source to the electrically conductive material for performing a medical procedure, and supplying energy from a RF source to the electrically conductive material for controlling bleeding at the surgical site. By means of non-limiting examples, such medical procedure may include cutting a tissue, sealing a tissue, and/or cauterizing a tissue. In some embodiments, the medical procedure includes controlling bleeding.
In accordance with other embodiments, a surgical instrument includes an elongated body having a distal end, a proximal end, and a bore extending between the distal and proximal ends, and a jaw assembly located at the distal end of the elongated body, the jaw assembly having an operative element for cutting a target tissue, wherein the jaw assembly has a protrusion for abutment against a critical tissue, and the protrusion is sized so that when the protrusion is abutted against the critical tissue, the operative element is automatically placed at a desired position relative to the target tissue. In some embodiments, the target tissue includes tissue at a side branch vessel. Also, in some embodiments, the critical tissue includes tissue at a main branch vessel.
In accordance with other embodiments, a surgical instrument includes an elongated body having a distal end, a proximal end, and a bore extending between the distal and proximal ends, and a jaw assembly located at the distal end of the elongated body, the jaw assembly configured for cutting a side branch vessel, wherein the jaw assembly has a first jaw, a second jaw, and an electrode secured to the first jaw, wherein the second jaw has a raised portion that faces towards the first jaw, and the electrode has two side electrode portions and a middle electrode portion that is between the two side electrode portions, the raised portion of the second jaw being in alignment with the middle electrode portion. In other embodiments, instead of cutting a side branch vessel, the jaw assembly may be used to cut other tissue, such as tissue at a main branch vessel, etc.
In accordance with other embodiments, a surgical instrument includes an elongated body having a distal end, a proximal end, and a bore extending between the distal and proximal ends, and a jaw assembly located at the distal end of the elongated body, the jaw assembly configured for cutting tissue, wherein the jaw assembly has a first jaw, a second jaw, and an electrode secured to the first jaw, wherein the electrode has two side electrode portions and a middle electrode portion that is between the two side electrode portions, the electrode is planar and extends beyond an edge of the first jaw, and the electrode is insulated by a non-conductive portion of the first jaw.
Other and further aspects and features will be evident from reading the following detailed description of the embodiments, which are intended to illustrate, not limit, the invention.
The drawings illustrate the design and utility of embodiments, in which similar elements are referred to by common reference numerals. These drawings are not necessarily drawn to scale. In order to better appreciate how the above-recited and other advantages and objects are obtained, a more particular description of the embodiments will be rendered, which are illustrated in the accompanying drawings. These drawings depict only typical embodiments and are not therefore to be considered limiting of its scope.
Various embodiments are described hereinafter with reference to the figures. It should be noted that the figures are not drawn to scale and that elements of similar structures or functions are represented by like reference numerals throughout the figures. It should also be noted that the figures are only intended to facilitate the description of the embodiments. They are not intended as an exhaustive description of the invention or as a limitation on the scope of the invention. In addition, an illustrated embodiment needs not have all the aspects or advantages shown. An aspect or an advantage described in conjunction with a particular embodiment is not necessarily limited to that embodiment and can be practiced in any other embodiments even if not so illustrated.
In the illustrated embodiments, the surgical device 14 includes a pair of jaws 21, 23 for clamping, cutting, and sealing a vessel. The jaw 21 includes an electrically conductive material 25 which faces towards the opposing jaw 23. Alternatively, or additionally, the jaw 23 may include an electrically conductive material which faces towards jaw 21. The electrically conductive material 25 is in a form of an electrode, and is configured to selectively provide heat or RF energy during use. As used in this specification, the term “electrode” refers to a component that is for delivering energy, such as heat energy, RF energy, etc., and thus, should not be limited to a component that delivers any particular form of energy. The electrically conductive material 25 may be Ni-chrome, stainless steel, or other metals or alloys in different embodiments. The jaws 21, 23 are configured to close in response to actuation (e.g., pressing, pulling, or pushing, etc.) of the button 15, thereby clamping a vessel during use. In the illustrated embodiments, the button 15 may be further actuated (e.g., further pressed, further pulled, or further pushed, etc.) to cause the electrically conductive material 25 to provide heat, thereby cutting and sealing the clamped vessel. In particular, when the button is further actuated, the electrically conductive material 25 is electrically coupled to a DC source 30, which provides a current to the electrically conductive material (electrode) 25, thereby heating the electrode 25. After the vessel is cut and sealed, the button 15 may be de-actuated to open the jaws 21, 23, thereby stopping the delivery of heat. The mechanical linkage for translating operation of the button 15 into closing and opening of the jaws 21, 23 may be implemented using cables, shafts, gears, or any of other mechanical devices that are known in the art.
In the illustrated embodiments, the handle 11 also includes an electrical contact region 17 that is in a form of a ring located near the distal end 16 of the handle 11. The contact region 17 is electrically coupled to the electrically conductive material 25 at the surgical device 14, and is configured (e.g., shaped, sized, and positioned) for receiving RF energy from a RF source. In some embodiments, the contact region 17 is electrically connected to the electrode 25 via electrical line that may be housed within a wall of the elongated body 13, or that may be in a form of a cable that is housed within the bore of the elongated body 13. In some embodiments, the elongated body 13 may include an outer layer of bioinert electrically insulative material. In other embodiments, instead of being in a form of a ring, the contact region 17 may be in a form of a small pad or other contact(s) located near the distal end 16 of the handle 11.
The linkage that mechanically couples the jaws 21, 23 to the actuator 15 may be electrically insulated, for example, by silicone rubber, ceramic or other suitable non-electrically conductive material. This assures that high frequency energy supplied to the contact region 17 is conducted along the electric line housed by the body 13 to the electrically conductive material (electrode) 25 at jaw 21 (and/or electrode at jaw 23). In other embodiments, the body 13 may not include an electric line for coupling the contact region 17 to the electrode 25. Instead, the linkage that mechanically couples the jaws 21, 23 to the actuator 15 may be electrically conductive, and is used to couple RF energy received at the contact region 17 to the electrode 25 at jaw 21 (and/or electrode at jaw 23). For example, the linkage may be slidably coupled to the contact region 17.
In operation, as illustrated in the partial perspective views of
It should be noted that the term “first mode” does not need to be associated with supplying RF energy, and that the term “second mode” does not need to be associated with supplying heat energy. As used in this specification, the terms “first mode” and “second mode” refer to different modes. Thus, in other embodiments, the first mode of operation may be achieved by supplying heat energy, and the second mode of operation may be achieved by supplying RF energy. Also, it should be noted that the operation of the button 31 may be reversed in other embodiments. In particular, in other embodiments, actuating the button 31 would enable delivery of heat energy (and disallow delivery of RF energy), and de-actuating the button 31 would enable delivery of RF energy (and disallow delivery of heat energy).
In the illustrated embodiments, operation of the manual actuator 15 allows selective delivery of heat energy or RF energy in different modes of operation. In some embodiments, activating the manual actuator 15 will result in closing of the jaw assembly. The activating of the manual actuator 15 will also configure an internal switch, which allows a current to be delivered to the conductive material 25 for providing heat, and prevents energy from the RF source from being delivered to the conductive material 25. When the manual actuator 15 is de-activated, the internal switch is configured in a different way, which allows RF energy to be delivered to the conductive material 25, and prevents energy from the DC source from being delivered to the conductive material 25. The internal switch will be described in further details below with reference to
As shown in
During use, in the first mode of operation, current from the DC source 30 is conducted through the center terminal 42, and flows in the middle portion 48 of the heater element 40 and in parallel through the dual outer portions 50, 52 of the heating element 40 to the common terminals 44, 46. Thus, for heater portions 48, 50, 52 of equal thicknesses and equal widths, current density in the middle portion 48 is twice as high as the current density in each of the outer portions 50, 52 in response to electrical heater signal applied between terminal 42 and the common terminals 44, 46. Of course, current densities in the center and outer portions 48, 50, 52 may be altered (for example, by altering the relative widths of the heater portions, by altering resistances through selection of different materials, by altering both the widths and resistances, etc.) to alter the operating temperatures thereof in response to applied electrical heater signals. In operation, the outer heater portions 50, 52 may operate at a temperature sufficient to weld a tissue structure (e.g., a blood vessel) grasped between the jaws 21, 23, and the center heater portion 48 may operate at a higher temperature sufficient to sever the grasped tissue structure intermediate the welded segments. In the second mode of operation, the heater element 40 does not receive current from the DC source 30. Instead, the heater element 40 operates as a RF electrode (e.g., a monopolar electrode) and delivers RF energy that is provided from the RF generator, and that is transmitted to the heater element 40 via the contact region 17. The application of the RF energy may be used to control bleeding at tissue that is at the surgical site, e.g., tissue that is next to the vessel being harvested, or tissue next to a side branch vessel, etc.
Referring now to
In the illustrated embodiments, the cross sections of the respective jaws 21, 23 are not symmetrical. Instead, jaw 21 has a protrusion 60, and jaw 23 has a protrusion 62. Each of the protrusions 60, 62 has a length so that when the protrusions 60, 62 abut against a main branch vessel MB, the cutting point of the side branch vessel SB is at a prescribed distance D that is spaced away from the main branch vessel MB (
As shown in
Referring now to the partial cutaway view of
During use, when the actuator 38 is pushed forward (by rotating about axis 90) to push rod 36, the translation motion of the rod 36 causes the jaws 21, 23 to open. The opened jaws 21, 23 can then be used to grasp tissue (e.g., side branch vessel). When the jaws 21, 23 are placed around target tissue, the actuator 38 may be pulled backward to pull rod 36. The translation motion of the rod 36 causes the jaws 21, 23 to close, thereby gripping the target tissue. If desired, the actuator 38 may be further pulled backward to cause the portion 92 of the actuator 38 to engage the lever 94 of the electrical switch 78. This in turn causes the first contact 95 to be electrically connected to the second contact 96 within the switch 78, thereby supplying DC power from the DC source to the heater element (electrode) 40. Inside the switch 78, when the second contact 96 is electrically connected to the first contact 95, the third contact 97 is electrically de-coupled from the first contact 95. Thus, while DC energy is being delivered to the electrode 40 (e.g., for providing heat to cut and/or weld tissue), the contact 74 will not be able to transmit RF energy (e.g., from an electrosurgical RF probe) to the electrode 40. The delivery of DC energy may be stopped by pushing the actuator 38 forward so that the portion 92 is disengaged from the lever 94. When this happens, the second contact 96 is electrically disconnected from the first contact 95 inside the switch 78, and the third contact 97 is electrically connected to the first contact 95 inside the switch 78. Such configuration allows RF energy (from the electrosurgical RF probe delivered at the contact 74 and transmitted to the third contact 97) to be transmitted to the electrode 40 (e.g., for bleeding control). Note that in this mode of operation, DC energy cannot be delivered to the electrode 40 because the first and second contacts of the switch 78 is not electrically connected.
Referring now to
During use of the surgical instrument 9, the body 13 is advanced along a vessel to be harvested. In some cases, the instrument 9 may be placed into an instrument channel of a cannula, which includes a viewing device, such as an endoscope, for allowing an operator to see the distal end of the instrument 9 inside the patient. When a side branch vessel (or other target tissue) is encountered, the jaws 21, 23 may be used to grasp and compress the side-branch vessel in response to manual manipulation of the actuator 38. Power is then supplied using the DC source 30 to the heater elements 48, 50, 52 (which function as resistive element that heats up in response to the delivered direct current) to effect tissue welds at tissues that are in contact with outer segments 50, 52, and to effect tissue cutting at tissue that is in contact with segment 48.
During the vessel harvesting procedure, if the operator notices that there is bleeding next to the vessel being harvested (e.g., at peripheral vasculature), the operator may position the electrosurgical RF probe 27 so that it is in contact with the contact region 17/74 at the handle 11. This results in RF energy being supplied (or allowed to be supplied) from the attached electrosurgical RF generator. In some cases, a foot-actuated switch may be provided that allows the operator to direct RF energy from the RF generator to the RF probe 27. The supplied RF energy from the RF generator is conducted to the electrically conductive material 25 at the distal surgical device 14, and the energy is returned via a return electrode pad that is coupled to a skin of the patient. The electrically conductive material 25 serves as a monopole RF electrode to electrocauterize any tissue (e.g., vessel tissue or surrounding tissue) that is grasped between the jaws 21, 23. Alternatively, the lateral edge of the heater element 52 that protrudes from a side of the jaw 21 may be used to cauterize bleeding area. In such cases, the jaws 21, 23 may or may not be closed, and may or may not be grasping any tissue. For example, in some embodiments, the operator may not be using the jaws 21, 23 to grasp or cut tissue. However, if the operator notices that there is bleeding at or near the surgical site, the operator may use the element 52 protruding from a side of the jaw 21 to cauterize the bleeding area (e.g., such as that shown in
In some embodiments, the exposed portion of the element 52 may also be used as a DC electrode for controlling bleeding. For example, the side or the tip of the element 52 that extends beyond the profile of the jaw assembly may be used to perform thermal spot cauterization by direct thermal conduction. In such cases, the element 52 may be heated up, and its exposed edge (or tip) may be used to touch tissue that is desired to be cauterized.
In the above embodiments, the surgical instrument 9 has been described as having contact region(s) for allowing a RF probe to make contact, thereby causing the surgical instrument 9 to deliver RF energy at its distal end. However, in other embodiments, the surgical instrument 9 may be configured to deliver RF energy without using any RF probe to make contact with it. For example, in other embodiments, the surgical instrument 9 may be coupled to the DC source 30 via a cable 200, wherein the cable 200 is for delivering DC energy from the DC source 30 to the surgical instrument 9 (
In other embodiments, the cable 200 may be coupled to a switch box 210. The switch box 210 is configured to receive energy from the DC source 30 and transmit it to the surgical instrument 9 in one mode of operation (
As illustrated in the above embodiments, the surgical instrument 9 allows delivering of heat to a remote surgical site for welding and severing vessel, and allows delivering of RF energy for cauterizing tissue to control bleeding. Such instrument is advantageous since combining heat delivery function with RF delivery function would allow a user to address two very different situations (e.g., tissue welding and bleeding control) using a single tool. Also, because many of the components in the instrument 9 that are for providing DC heating are also used for delivering RF energy, the instrument 9 maintains a low profile without any substantial increase in its size. Furthermore, the instrument 9 allows delivery of RF energy in a controlled manner, thereby protecting the vessel being harvested while allowing bleeding to be controlled. Embodiments of the instrument 9 is also advantageous in that it obviates the need for repeatedly inserting a separate bleeding control device inside the patient to control bleeding, and removing such bleeding control device from the patient, during a vessel harvesting procedure. Thus, embodiments of the surgical instrument 9 described herein allows delivery of RF energy in a way that makes it much easier to address bleeding.
Although the above embodiments have been described with reference to the surgical device 14 being a pair of jaws for clamping, cutting, and sealing vessel (e.g., saphenous vein, an artery, or any other vessel), in other embodiments, the surgical device 14 may have different configurations, and different functionalities. For example, in other embodiments, the surgical device 14 may be clip appliers or grasping jaws with no heating functionality, but still include one or more high frequency electrodes for delivering RF energy from RF source to control bleeding. In further embodiments, the bleeding control feature (e.g., the components for allowing RF to be delivered to the distal end of the surgical instrument) may be incorporated in any type of laparoscopic/endoscopic surgical tool. Also, in any of the embodiments described herein, the surgical instrument 9 may be used in any endoscopic procedure that requires transection of tissue with bleeding control.
In addition, although the above embodiments have been described with reference to delivering heat energy and RF energy in different times, in other embodiments, the surgical instrument 9 may be configured to deliver heat energy and RF energy simultaneously. For example, in other embodiments, the surgical instrument 9 may include an electrode for delivering heat energy to cut and/or seal tissue, and another electrode for delivering RF energy for bleeding control. In other embodiments, the surgical instrument 9 may include an operative element for simultaneously delivering heat and RF energy.
Also, although the above embodiments have been described with reference to a surgical instrument that has a bleeding control feature, in other embodiments, such bleeding control feature is optional. Thus, in any of the embodiments described herein, the surgical instrument 9 may not include the port(s) 34, the contact region 17/contact device 74, and the electrical switch 78. In addition, in any of the embodiments described herein, the jaw assembly at the distal end of the surgical instrument 9 does not need to include all of the features described herein. For example, in some embodiments, the jaw assembly does not include outer electrode portions 50, 52. Instead, the jaw assembly includes one electrode strip (like the middle electrode portion 48 described above) for cutting or sealing tissue. Furthermore, in other embodiments, the jaw 23 may not have the raised portion 54. Instead, the jaw 23 may have a flat surface that is for contacting the electrode portions 48, 50, 52. In addition, in further embodiments, the jaws 21, 23 may not include the respective protrusions 60, 62. Instead, the cross section of the jaw 21/23 may have a symmetrical configuration. In other embodiments, protrusion(s) may be provided on both sides of the jaw assembly (e.g., one or more protrusions at the concave side of the jaw assembly, and one or more protrusions at the convex side of the jaw assembly). Such configuration provides buffering on both sides of the jaw assembly, and allows for correct placement of the jaw assembly regardless of which side (the concave or convex side) of the jaw assembly is oriented towards the main branch vessel MB during use. In further embodiments, instead of the curved configuration, the jaws could be straight. Also, in any of the embodiments described herein, instead of, or in addition to, using the electrode 40 for controlling bleeding, the electrode 40 may be used for dissection or transection of tissue, such as fatty and connective tissue encountered during a vessel harvesting procedure.
Although particular embodiments have been shown and described, it will be understood that they are not intended to limit the present inventions, and it will be obvious to those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the present inventions. The specification and drawings are, accordingly, to be regarded in an illustrative rather than restrictive sense. The present inventions are intended to cover alternatives, modifications, and equivalents, which may be included within the spirit and scope of the present inventions as defined by the claims.
This application claims priority to, and the benefit of, U.S. Provisional Application Ser. No. 61/056,207, filed on May 27, 2008, the entire disclosure of which is expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2137710 | Anderson | Dec 1937 | A |
4031898 | Hiltebrandt et al. | Jun 1977 | A |
4071028 | Perkins | Jan 1978 | A |
4128099 | Bauer | Dec 1978 | A |
4281646 | Kinoshita | Aug 1981 | A |
4418692 | Guay | Dec 1983 | A |
4468217 | Kuzmick et al. | Aug 1984 | A |
4759362 | Taniguchi | Jul 1988 | A |
4767519 | de Nora | Aug 1988 | A |
4801015 | Lubock et al. | Jan 1989 | A |
4884559 | Collins | Dec 1989 | A |
5009661 | Michelson | Apr 1991 | A |
5052402 | Bencini et al. | Oct 1991 | A |
5098430 | Fleenor | Mar 1992 | A |
5108474 | Riedy et al. | Apr 1992 | A |
5147356 | Bhatta | Sep 1992 | A |
5151102 | Kamiyama et al. | Sep 1992 | A |
5154709 | Johnson | Oct 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5160334 | Billings et al. | Nov 1992 | A |
5217460 | Knoepfler | Jun 1993 | A |
5258006 | Rydell et al. | Nov 1993 | A |
5282799 | Rydell | Feb 1994 | A |
5290278 | Anderson | Mar 1994 | A |
5300065 | Anderson | Apr 1994 | A |
5312426 | Segawa et al. | May 1994 | A |
5314424 | Nicholas | May 1994 | A |
5318040 | Kensey et al. | Jun 1994 | A |
5336221 | Anderson | Aug 1994 | A |
5342381 | Tidemand | Aug 1994 | A |
5352222 | Rydell | Oct 1994 | A |
5356408 | Rydell | Oct 1994 | A |
5361583 | Huitema | Nov 1994 | A |
5364395 | West, Jr. | Nov 1994 | A |
5383888 | Zvenyatsky et al. | Jan 1995 | A |
5405344 | Williamson et al. | Apr 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5451222 | De Maagd et al. | Sep 1995 | A |
5453599 | Hall, Jr. | Sep 1995 | A |
5462546 | Rydell | Oct 1995 | A |
5472442 | Klicek | Dec 1995 | A |
5496317 | Goble et al. | Mar 1996 | A |
5507744 | Tay et al. | Apr 1996 | A |
5507773 | Huitema et al. | Apr 1996 | A |
5509922 | Aranyi et al. | Apr 1996 | A |
5514134 | Rydell et al. | May 1996 | A |
5562503 | Eliman et al. | Oct 1996 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5624452 | Yates | Apr 1997 | A |
5647871 | Levine et al. | Jul 1997 | A |
5669934 | Sawyer | Sep 1997 | A |
5674219 | Monson et al. | Oct 1997 | A |
5683412 | Scarfone | Nov 1997 | A |
5709675 | Williams | Jan 1998 | A |
5709680 | Yates et al. | Jan 1998 | A |
5716366 | Yates | Feb 1998 | A |
5722962 | Garcia | Mar 1998 | A |
5741285 | McBrayer et al. | Apr 1998 | A |
5752973 | Kieturakis | May 1998 | A |
5755717 | Yates et al. | May 1998 | A |
5766134 | Lisak et al. | Jun 1998 | A |
5766166 | Hooven | Jun 1998 | A |
5776130 | Buysse et al. | Jul 1998 | A |
5807393 | Williamson et al. | Sep 1998 | A |
5810810 | Tay et al. | Sep 1998 | A |
5827271 | Buysse et al. | Oct 1998 | A |
5833690 | Yates et al. | Nov 1998 | A |
5843017 | Yoon | Dec 1998 | A |
5849011 | Jones et al. | Dec 1998 | A |
5853410 | Greff et al. | Dec 1998 | A |
5860975 | Goble et al. | Jan 1999 | A |
5871496 | Ginn et al. | Feb 1999 | A |
5891141 | Rydell | Apr 1999 | A |
5906630 | Anderhub et al. | May 1999 | A |
5908420 | Parins et al. | Jun 1999 | A |
5911719 | Eggers | Jun 1999 | A |
5944718 | Austin et al. | Aug 1999 | A |
5947984 | Whipple | Sep 1999 | A |
5954686 | Garito et al. | Sep 1999 | A |
5997533 | Kuhns | Dec 1999 | A |
6004320 | Casscells et al. | Dec 1999 | A |
6022313 | Ginn et al. | Feb 2000 | A |
6024741 | Williamson et al. | Feb 2000 | A |
6027501 | Goble et al. | Feb 2000 | A |
6033424 | Ouchi | Mar 2000 | A |
6039733 | Buysse et al. | Mar 2000 | A |
6059781 | Yamanashi et al. | May 2000 | A |
6066151 | Miyawaki et al. | May 2000 | A |
6074389 | Levine et al. | Jun 2000 | A |
6110190 | Ginn et al. | Aug 2000 | A |
6113596 | Hooven et al. | Sep 2000 | A |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6179837 | Hooven | Jan 2001 | B1 |
6190386 | Rydell | Feb 2001 | B1 |
6206876 | Levine et al. | Mar 2001 | B1 |
6254623 | Haibel et al. | Jul 2001 | B1 |
6267761 | Ryan | Jul 2001 | B1 |
6270497 | Sekino et al. | Aug 2001 | B1 |
6273887 | Yamauchi et al. | Aug 2001 | B1 |
6352503 | Matsui et al. | Mar 2002 | B1 |
6352532 | Kramer et al. | Mar 2002 | B1 |
6391029 | Hooven et al. | May 2002 | B1 |
6406454 | Hajianpour | Jun 2002 | B1 |
6432105 | Ellman et al. | Aug 2002 | B1 |
6458122 | Pozzato | Oct 2002 | B1 |
6464701 | Hooven et al. | Oct 2002 | B1 |
6478794 | Trapp et al. | Nov 2002 | B1 |
6517536 | Hooven et al. | Feb 2003 | B2 |
6524307 | Palmerton et al. | Feb 2003 | B1 |
6527771 | Weadock et al. | Mar 2003 | B1 |
6544210 | Trudel et al. | Apr 2003 | B1 |
6551313 | Levin | Apr 2003 | B1 |
6576033 | Booth | Jun 2003 | B1 |
6582451 | Marucci et al. | Jun 2003 | B1 |
6582582 | Becking | Jun 2003 | B2 |
6602252 | Mollenauer | Aug 2003 | B2 |
6613069 | Boyd et al. | Sep 2003 | B2 |
6626901 | Treat et al. | Sep 2003 | B1 |
6652514 | Eliman et al. | Nov 2003 | B2 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6663610 | Thompson et al. | Dec 2003 | B1 |
6682528 | Frazier et al. | Jan 2004 | B2 |
6685665 | Booth et al. | Feb 2004 | B2 |
6695837 | Howell | Feb 2004 | B2 |
6746504 | Booth | Jun 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6773409 | Truckai et al. | Aug 2004 | B2 |
6802843 | Truckai et al. | Oct 2004 | B2 |
6821273 | Mollenauer | Nov 2004 | B2 |
6830569 | Thompson et al. | Dec 2004 | B2 |
6860880 | Treat et al. | Mar 2005 | B2 |
6908463 | Treat et al. | Jun 2005 | B2 |
6958070 | Witt et al. | Oct 2005 | B2 |
6966907 | Goble | Nov 2005 | B2 |
6966909 | Marshall et al. | Nov 2005 | B2 |
6994707 | Ellman et al. | Feb 2006 | B2 |
7033356 | Latterell et al. | Apr 2006 | B2 |
7094231 | Eliman et al. | Aug 2006 | B1 |
7112199 | Cosmescu | Sep 2006 | B2 |
7147637 | Goble | Dec 2006 | B2 |
7204835 | Latterell et al. | Apr 2007 | B2 |
7211080 | Treat et al. | May 2007 | B2 |
7316683 | Kasahara et al. | Jan 2008 | B2 |
7326202 | McGaffigan | Feb 2008 | B2 |
7329257 | Kanehira et al. | Feb 2008 | B2 |
7364577 | Wham et al. | Apr 2008 | B2 |
7367976 | Lawes et al. | May 2008 | B2 |
7396356 | Mollenauer | Jul 2008 | B2 |
7513896 | Orszulak | Apr 2009 | B2 |
7632270 | Livneh | Dec 2009 | B2 |
7645289 | Bayer | Jan 2010 | B2 |
7695470 | Stewart et al. | Apr 2010 | B1 |
7699861 | Bayer | Apr 2010 | B2 |
7887558 | Lin et al. | Feb 2011 | B2 |
7918845 | Saadat et al. | Apr 2011 | B2 |
7918848 | Lau et al. | Apr 2011 | B2 |
8197472 | Lau et al. | Jun 2012 | B2 |
8221306 | Okada et al. | Jul 2012 | B2 |
8251989 | Newton et al. | Aug 2012 | B1 |
8257352 | Lawes et al. | Sep 2012 | B2 |
8425508 | Kasahara et al. | Apr 2013 | B2 |
8657818 | Lin | Feb 2014 | B2 |
20020019631 | Kidder et al. | Feb 2002 | A1 |
20020058938 | Cosmescu | May 2002 | A1 |
20020115997 | Truckai et al. | Aug 2002 | A1 |
20020128603 | Booth et al. | Sep 2002 | A1 |
20030014052 | Buysse et al. | Jan 2003 | A1 |
20030060816 | Iida | Mar 2003 | A1 |
20030073991 | Francischelli | Apr 2003 | A1 |
20030125734 | Mollenauer | Jul 2003 | A1 |
20030130654 | Kasahara et al. | Jul 2003 | A1 |
20030130674 | Kasahara et al. | Jul 2003 | A1 |
20030130675 | Kasahara et al. | Jul 2003 | A1 |
20030139649 | Kasahara et al. | Jul 2003 | A1 |
20030144652 | Baker et al. | Jul 2003 | A1 |
20030144660 | Mollenauer | Jul 2003 | A1 |
20030163123 | Goble et al. | Aug 2003 | A1 |
20030171747 | Kanehira et al. | Sep 2003 | A1 |
20030187429 | Karasawa et al. | Oct 2003 | A1 |
20040054365 | Goble | Mar 2004 | A1 |
20040064151 | Mollenauer | Apr 2004 | A1 |
20040078035 | Kanehira et al. | Apr 2004 | A1 |
20040102450 | Ewing et al. | May 2004 | A1 |
20040133228 | Bayer | Jul 2004 | A1 |
20040176756 | McGaffigan | Sep 2004 | A1 |
20040204725 | Bayer | Oct 2004 | A1 |
20040260279 | Goble et al. | Dec 2004 | A1 |
20050033278 | McClurken et al. | Feb 2005 | A1 |
20050049633 | Watanabe | Mar 2005 | A1 |
20050072827 | Mollenauer | Apr 2005 | A1 |
20050113826 | Johnson et al. | May 2005 | A1 |
20050171533 | Latterell et al. | Aug 2005 | A1 |
20060074444 | Lin et al. | Apr 2006 | A1 |
20060211916 | Kasahara et al. | Sep 2006 | A1 |
20060217697 | Lau et al. | Sep 2006 | A1 |
20060217706 | Lau et al. | Sep 2006 | A1 |
20060235379 | McClurken et al. | Oct 2006 | A1 |
20060271037 | Maroney et al. | Nov 2006 | A1 |
20070021405 | Abouabdellah et al. | Jan 2007 | A1 |
20070021424 | Abouabdellah et al. | Jan 2007 | A1 |
20070027141 | Abouabdellah et al. | Feb 2007 | A1 |
20070078456 | Dumbauld et al. | Apr 2007 | A1 |
20070149993 | Kasahara et al. | Jun 2007 | A1 |
20070213749 | Kogasaka et al. | Sep 2007 | A1 |
20070260242 | Dycus et al. | Nov 2007 | A1 |
20070293856 | Paul et al. | Dec 2007 | A1 |
20070293858 | Fischer | Dec 2007 | A1 |
20080015567 | Kimura | Jan 2008 | A1 |
20080015575 | Odom et al. | Jan 2008 | A1 |
20080039835 | Johnson et al. | Feb 2008 | A1 |
20080154091 | Dejima et al. | Jun 2008 | A1 |
20080306335 | Lau et al. | Dec 2008 | A1 |
20090024121 | Kasahara et al. | Jan 2009 | A1 |
20090118730 | Mollenauer | May 2009 | A1 |
20090299367 | Ginnebaugh et al. | Dec 2009 | A1 |
20100048992 | Okada et al. | Feb 2010 | A1 |
20100292533 | Kasahara et al. | Nov 2010 | A1 |
20110046439 | Pamnani et al. | Feb 2011 | A1 |
20110046624 | Lin | Feb 2011 | A1 |
20110257643 | Lau et al. | Oct 2011 | A1 |
20110288369 | Ginnebaugh et al. | Nov 2011 | A1 |
20110288546 | Abbott et al. | Nov 2011 | A1 |
Number | Date | Country |
---|---|---|
1330991 | Jul 2003 | EP |
1632192 | Mar 2006 | EP |
1878399 | Jan 2008 | EP |
1894535 | Mar 2008 | EP |
2005048863 | Jun 2005 | WO |
2009039179 | Mar 2009 | WO |
Entry |
---|
International Search Report and Written Opinion dated Jan. 19, 2010 for PCT Application No. PCT/US2009/045272. |
Number | Date | Country | |
---|---|---|---|
20090299367 A1 | Dec 2009 | US |
Number | Date | Country | |
---|---|---|---|
61056207 | May 2008 | US |